Source disclosure: February 25, 2026, 16:00 JST
Solasia Pharma K.K. [4597.T]
TOKYO, Feb 25 (Pulse News Wire) – Solasia Pharma K.K. (4597.T) completed the exercise of its warrant issue 15 with an adjusted exercise price clause.
Additionally, the company reported monthly exercise activity for February 2026, which included the issuance of 3,749,900 shares on February 25. During the month of February, 28 warrants were exercised, representing approximately 0.00018% of the total outstanding warrants. As of the end of January, there were 26 unexercised warrants, equivalent to 43 shares.
By the end of February, all remaining warrants had been exercised, leaving none outstanding. In relation to exercise limitations based on the Tokyo Stock Exchange's Listing Regulations Article 434 and the Securities Association’s Rules on Handling Third-Party Allotment Equity Issues, Solasia Pharma adhered to the restrictions. The combined number of exercisable securities was 218,458,910, with the ratio of exercised securities to the total number of outstanding shares being 1.72%.
AI-translated content. 🟢 Confidence: High See terms • Original filing